Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Elvis Picardo is a regular contributor to Investopedia and has 25+ years of experience as a portfolio manager with diverse capital markets experience. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is ...

As 2025 comes to an end, we take a look back at our favorite pictures of the year in The Morning Call. The former Wells Fargo bank branch in downtown Bethlehem would get a 5-story addition for 61 ...

Cesar Martes Cedano was arrested in late November on charges alleging he used a stolen corporate credit card from a Lehigh Valley nonprofit; police say during a search of his home they found hundreds ...